Circulating osteoglycin and NGAL/MMP9 complex concentrations predict 1-year major adverse cardiovascular events after coronary angiography

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 34, Issue 5, 2014, Pages 1078-1084

  Cheng, Jin M ^a   Akkerhuis, K Martijn ^a   Meilhac, Olivier ^b,c   Oemrawsingh, Rohit M ^a   Garcia Garcia, Hector M ^a   Van Geuns, Robert Jan ^a   Piquer, Dominique ^d   Merle, Delphine ^d   Du Paty, Emilie ^d   Galéa, Pascale ^d   Jaisser, Frederic ^e   Rossignol, Patrick ^e,f,g   Serruys, Patrick W ^a   Boersma, Eric ^a   Fareh, Jeannette ^d   Kardys, Isabella ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b BICHAT HOSPITAL   (France)

^c CHU de La Réunion site centre hospitalier Félix Guyon   (France)

^d SYSDIAG   (France)

^e INSERM   (France)

^f UNIVERSITY HOSPITAL OF NANCY   (France)

^g UNIVERSITÉ DE LORRAINE   (France)

Author keywords

atherosclerosis; biological markers; OGN protein, human; prognosis

Indexed keywords

BINDING PROTEIN; C REACTIVE PROTEIN; DJ 1 PROTEIN; GELATINASE B; GLYCOPROTEIN; HEAT SHOCK PROTEIN 27; MICROFIBRIL ASSOCIATED GLYCOPROTEIN 4; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OSTEOGLYCIN; PEROXIREDOXIN 2; PHOSPHATIDYLETHANOL AMINE BINDING PROTEIN 1; PRO B TYPE NATRIURETIC PROTEIN 1; PROCOLLAGEN C PROTEINASE; PROCOLLAGEN C PROTEINASE ENHANCER 1; PROTEIN; SYNAPSIN I; THROMBOSPONDIN 2; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ADULT; AGE; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; STABLE ANGINA PECTORIS;

ATHEROSCLEROSIS; BIOLOGICAL MARKERS; OGN PROTEIN, HUMAN; PROGNOSIS;

ACUTE CORONARY SYNDROME; ACUTE-PHASE PROTEINS; AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOCALINS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; RISK FACTORS; ROC CURVE; STROKE; TIME FACTORS;

EID: 84899651042     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.303486     Document Type: Article

References (24)

1. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-1143.
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695.
3. James SK, Armstrong P, Barnathan E, Califf R, Lindahl B, Siegbahn A, Simoons ML, Topol EJ, Venge P, Wallentin L; GUSTO-IV-ACS Investigators. Troponin and C-reactive protein have different relations to subsequent mortality and myocardial infarction after acute coronary syndrome: a GUSTO-IV substudy. J Am Coll Cardiol. 2003;41:916-924.
4. Makrygiannis SS, Ampartzidou OS, Zairis MN, Patsourakos NG, Pitsavos C, Tousoulis D, Prekates AA, Foussas SG, Cokkinos DV. Prognostic usefulness of serial C-reactive protein measurements in ST-elevation acute myocardial infarction. Am J Cardiol. 2013;111:26-30.
5. Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, Hsia J, Gersh BJ, Rifai N, Ridker PM, Pfeffer MA, Braunwald E; PEACE Investigators. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation. 2007;115:1528-1536.
6. Tuñón J, Martín-Ventura JL, Blanco-Colio LM, Lorenzo O, López JA, Egido J. Proteomic strategies in the search of new biomarkers in atherothrombosis. J Am Coll Cardiol. 2010;55:2009-2016.
7. Gerszten RE, Wang TJ. The search for new cardiovascular biomarkers. Nature. 2008;451:949-952.
8. Malaud E, Merle D, Piquer D, et al. Local carotid atherosclerotic plaque proteins for the identification of circulating biomarkers in coronary patients. Atherosclerosis. 2014;233:551-558.
9. Hemdahl AL, Gabrielsen A, Zhu C, Eriksson P, Hedin U, Kastrup J, Thorén P, Hansson GK. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler Thromb Vasc Biol. 2006;26:136-142.
10. te Boekhorst BC, Bovens SM, Hellings WE, van der Kraak PH, van de Kolk KW, Vink A, Moll FL, van Oosterhout MF, de Vries JP, Doevendans PA, Goumans MJ, de Kleijn DP, van Echteld CJ, Pasterkamp G, Sluijter JP. Molecular MRI of murine atherosclerotic plaque targeting NGAL: a protein associated with unstable human plaque characteristics. Cardiovasc Res. 2011;89:680-688.
11. Leclercq A, Houard X, Philippe M, Ollivier V, Sebbag U, Meilhac O, Michel JB. Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment. J Leukoc Biol. 2007;82:1420-1429.
12. van Lammeren GW, Pasterkamp G, de Vries JP, Bosch L, de Haan JJ, de Kleijn DP, Moll FL, Vink A. Platelets enter atherosclerotic plaque via intraplaque microvascular leakage and intraplaque hemorrhage: a histopathological study in carotid plaques. Atherosclerosis. 2012;222:355-359.
13. Fernández B, Kampmann A, Pipp F, Zimmermann R, Schaper W. Osteoglycin expression and localization in rabbit tissues and atherosclerotic plaques. Mol Cell Biochem. 2003;246:3-11.
14. Shanahan CM, Cary NR, Osbourn JK, Weissberg PL. Identification of osteoglycin as a component of the vascular matrix. Differential expression by vascular smooth muscle cells during neointima formation and in atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 1997;17:2437-2447.
15. Thieszen SL, Rosenquist TH. Expression of collagens and decorin during aortic arch artery development: implications for matrix pattern formation. Matrix Biol. 1995;14:573-582.
16. Majesky MW, Lindner V, Twardzik DR, Schwartz SM, Reidy MA. Production of transforming growth factor beta 1 during repair of arterial injury. J Clin Invest. 1991;88:904-910.
17. Friedl A, Stoesz SP, Buckley P, Gould MN. Neutrophil gelatinase- associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression. Histochem J. 1999;31:433-441.
18. Latouche C, El Moghrabi S, Messaoudi S, Nguyen Dinh Cat A, Hernandez-Diaz I, Alvarez de la Rosa D, Perret C, López Andrés N, Rossignol P, Zannad F, Farman N, Jaisser F. Neutrophil gelatinase-associated lipocalin is a novel mineralocorticoid target in the cardiovascular system. Hypertension. 2012;59:966-972.
19. Yan L, Borregaard N, Kjeldsen L, Moses MA. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem. 2001;276:37258-37265.
20. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res. 2002;90:251-262.
21. Wang KF, Huang PH, Chiang CH, Hsu CY, Leu HB, Chen JW, Lin SJ. Usefulness of plasma matrix metalloproteinase-9 level in predicting future coronary revascularization in patients after acute myocardial infarction. Coron Artery Dis. 2013;24:23-28.
22. Daniels LB, Barrett-Connor E, Clopton P, Laughlin GA, Ix JH, Maisel AS. Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: the Rancho Bernardo Study. J Am Coll Cardiol. 2012;59:1101-1109.
23. Cavusoglu E, Ruwende C, Chopra V, Yanamadala S, Eng C, Clark LT, Pinsky DJ, Marmur JD. Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction. Am Heart J. 2006;151:1101.e1-e8.
24. de Lemos JA, Morrow DA. Brain natriuretic peptide measurement in acute coronary syndromes: ready for clinical application? Circulation. 2002;106:2868-2870.